Status:

UNKNOWN

The Efficacy of Viscosupplementation for Early Knee Osteoarthritis

Lead Sponsor:

University of Oxford

Conditions:

Knee Osteoarthritis

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

Treatment for early osteoarthritis (OA) of the knee is an increasing problem yet much of the research into OA, to date, concentrates on predisposition, genetic and cellular aspects and the treatment o...

Eligibility Criteria

Inclusion

  • 18-70 years
  • Radiographic evidence of OA in the tibiofemoral compartment (minute or definite osteophytes and a measurable joint space)
  • Pain on walking (Visual Analogue Scale 0-10). Minimum of 4 and maximum of 9.
  • Oxford knee score (OKS) of above 12 but below 36 (0-48, 48 no problem)
  • Pain score of 1, 2 or 3 on Q1 (pain) of OKS.
  • Suitable for viscosupplementation

Exclusion

  • OKS of below 12 and above 36 (0-48, 48 no problem)
  • Pain score of 0 or 4 on Q1 (pain) of OKS.
  • Grade 3 or 4 patellofemoral degeneration (Kellgren-Lawrence classification).
  • Grade 3 or 4 tibiofemoral degeneration (Kellgren-Lawrence classification).
  • A clinically apparent tense effusion of the target knee.
  • Significant valgus/varus deformities.
  • Ligamentous laxity or meniscal instability.
  • Viscosupplementation history in any joint in the past 9 months.
  • Previous surgery at the target knee in the past 6 months.
  • Concomitant inflammatory disease (rheumatoid arthritis) or other condition that affects the joints.
  • Use of prohibited medication/treatment for chronic pain.
  • Pregnancy or new mothers who are breastfeeding.
  • Systemic or intra-articular injection of corticosteroids in any joint within 3 months prior to screening.
  • Obvious cartilage defects producing mechanical symptoms (i.e. locking).
  • Listed for a knee replacement procedure for osteoarthritis of the knee.
  • Have a history of failed conservative treatment (exercise therapy, physiotherapy).

Key Trial Info

Start Date :

May 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2013

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT01210742

Start Date

May 1 2011

End Date

October 1 2013

Last Update

June 18 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Nuffield Orthopaedic Centre, Biomedical Research Unit (BRU)

Oxford, England, United Kingdom, OX3 7LD